Crossmark

Relationship of dietary intake and eating behaviors with glycemic control and body weight under long-term treatment with dapagliflozin: an exploratory prospective study

Crossref DOI link: https://doi.org/10.1007/s13340-025-00794-1

Published Online: 2025-01-24

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yokomizo, Hisashi https://orcid.org/0000-0001-7759-2014
Kawanami, Daiji

Sonoda, Noriyuki

Ono, Yasuhiro

Maeda, Yasutaka

Itoh, Jun

Tohyama, Takeshi

Hirose, Masayuki

Watanabe, Hiroko

Kishimoto, Junji

Ogawa, Yoshihiro

Inoguchi, Toyoshi
Funding

Funding for this research was provided by:

AstraZeneca (ESR-14-10421)

Ono Pharmaceutical (ESR-14-10421)
License Information

Text and Data Mining valid from 2025-01-24

Version of Record valid from 2025-01-24
More Information

Article History

Received: 22 August 2024

Accepted: 9 January 2025

First Online: 24 January 2025

Declarations

:

: No potential conflicts of interest relevant to this article were reported.

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This study was approved by the Ethics Committee of the Kyushu University Hospital (Date of approval: August 12, 2015. Approval number: 26058).

: Informed consent was obtained from all the participants.

Document is current

Any future updates will be listed below